Fresenius Granuflo Puts Dialysis Patients At Risk For A Heart Attack And Other Serious Health Complications
Domengeaux, Wright, Roy and Edwards of Lafayette, Louisiana is investigating the potential link between the Fresenius Naturalyte Liquid and the GranuFlo dry acid dialysis products that are used in many dialysis centers across the nation and several reports of heart attacks and other cardiac episodes during and while on dialysis. The complications and injuries are serious and dialysis patients who have been treated with these products are at risk.
GranuFlo is a dry acid product manufactured by the Fresenius Medical Care company and used during the process of dialysis. Dialysis removes toxic wastes from the body when the kidneys are unable too. Bicarbonates are administered to neutralize the acid build-up that occurs in the blood during the process. The Fresenius GranuFlo product allows for greater conversion of bicarbonates than other product and is used in Fresenius’ dialysis clinics as well as used on an estimated 125,000 patients in clinics operated by other dialysis providers and centers. As the Fresenius website states, this makes GranuFlo the “most-widely prescribed dry acid product in the dialysis industry.”
Cardiac Arrest Dangers During Dialysis
Because the Fresenius Granuflo is so widely distributed, their are many dialysis patients who are at risk of injury, complications and even death. Some data suggests that these cardiac events may be four to six times as likely to occur when GranuFlo dry acid product is administered.
A November 4, 2011 internal memo warned doctors practicing at Fresenius’ own medical centers that as many as 941 patients had suffered cardiac arrest due to the improper administration of the GranuFlo dry acid product. The memo indicated that the elevated bicarbonate levels contributed to an increase in the risk of sudden cardiac arrest.
As result of Fresenius Medical not reporting the possible risk of cardiac arrest, the Food and Drug Administration began to investigate. In June of 2012, the issued a recall.
Potential Complications From Granuflo
Some of the complications that can arise from the use of the Fresenius Granuflo dry acid and Naturalyte Liquid products are:
- Sudden Cardiac Arrest
- Sudden Heart Attack
- Hemodialysis cardiac arrest
- Hemodialysis cardiopulmonary arrest
- Altered Mental Status
- Low Blood Pressure
Physicians who were not aware of the extra bicarbonate resulting from GranuFlo® dry acid and NaturaLyte® liquid, may have prescribed even more bicarbonates, essentially giving there patients an overdose. The resulting excessive levels of alkaline may lead to serious heart problems.
If you or a loved has been on dialysis and has experienced any one of the above complications, then give the offices of Domengeaux, Wright, Roy and Edwards a call today at 888-326-8343. You may also fill out the form to your left to begin the conversation right now. When you come in to our office, the consultation is always free and confidential.